Amedisys Inc (AMED) earnings
AMED earnings moved a median of +0.29% by the close. Quarterly and annual AMED reports and results, each read against the price at its own news timestamp. Back to the AMED overview →
17 measured AMED earnings events.
Where these AMED earnings landedvs 17 measured AMED earnings reactions
| Middle 50% of AMED earnings reactions | -0.56% to +0.29% |
|---|---|
| Median reaction (to close) | +0.29% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 AMED earnings events with a measured close landed between -0.56% and +0.29%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AMEDISYS INC For: Jun 30 | SEC filing · Form 10-Q | +0.01% | +0.77% | |
| Amedisys Reports Second Quarter 2025 Financial Results | Press release | -0.43% | +0.29% | |
| Form 10-K/A AMEDISYS INC For: Dec 31 | SEC filing · Form 10-K | -0.18% | +0.32% | |
| Form 10-Q AMEDISYS INC For: Mar 31 | SEC filing · Form 10-Q | +0.11% | +0.29% | |
| Amedisys Reports First Quarter 2025 Financial Results | Press release | +0.11% | +0.29% | |
| Form 10-K/A AMEDISYS INC For: Dec 31 | SEC filing · Form 10-K | +0.28% | +0.50% | |
| Form 10-K AMEDISYS INC For: Dec 31 | SEC filing · Form 10-K | -0.65% | -0.65% | |
| Form 10-Q AMEDISYS INC For: Sep 30 | SEC filing · Form 10-Q | -0.57% | -0.83% | |
| Amedisys Reports Third Quarter 2024 Financial Results | Press release | -0.57% | -0.83% | |
| Form 10-Q AMEDISYS INC For: Jun 30 | SEC filing · Form 10-Q | -0.32% | -0.56% | |
| Amedisys Reports Second Quarter 2024 Financial Results | Press release | -0.32% | -0.56% | |
| Form 10-K/A AMEDISYS INC For: Dec 31 | SEC filing · Form 10-K | +0.25% | -0.30% | |
| Form 10-Q AMEDISYS INC For: Mar 31 | SEC filing · Form 10-Q | -0.37% | +0.29% | |
| Amedisys Reports First Quarter 2024 Financial Results | Press release | -0.37% | +0.29% | |
| Form 10-K AMEDISYS INC For: Dec 31 | SEC filing · Form 10-K | +0.02% | +0.65% | |
| Form 10-Q AMEDISYS INC For: Sep 30 | SEC filing · Form 10-Q | +1.35% | -0.06% | |
| Amedisys Reports Third Quarter 2023 Financial Results | Press release | +1.35% | -0.06% |
Keep exploring
More AMED: analyst actions → · SEC filings → · AMED overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Biomerica, Inc. (BMRA) | 135 | 0.00% | 49% |
| BioStem Technologies, Inc. (BSEM) | 135 | +0.30% | 53% |
| ISODIOL INTERNATIONAL INC (ISOLF) | 134 | +0.20% | 52% |
| ContextLogic Inc. (LOGC) | 132 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.